Children's Hospital of Philadelphia, Investigational Drug Service

3401 Civic Center Boulevard
Philadelphia, Pennsylvania 19104

We've found

2 trials

at this facility

Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Philadelphia, PA

Safety Of Rivipansel (GMI-1070) In The Treatment Of One or More Vaso-occlusive Crises In Hospitalized Subjects With Sickle Cell Disease

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Philadelphia, PA

Use our guide to learn which trials are right for you!